Children’s Hospital of Philadelphia, Mount Sinai open fetal medicine, heart programs

A ribbon-cutting ceremony held this week celebrated the opening of a fetal medicine and children’s heart program at Mount Sinai Hospital in New York.

The opening of the programs is a joint initiative by Mount Sinai and the Children’s Hospital of Philadelphia (CHOP), according to a May 31 press release form the providers. Their alliance, which is 18 months old, will provide the first services of its kind in the city.

“Mount Sinai is pleased to collaborate with CHOP, a world-renowned institution, to ensure excellent patient care," said Kenneth L. Davis, MD, president and CEO of the Mount Sinai Health System, in a statement. "Our goal is to offer the highest quality maternal, fetal, and pediatric care to patients—especially those with complex needs—across a large health system and a fast-growing ambulatory care network. And together, we will be uniquely positioned to recruit and retain the best faculty in the region."

The fetal medicine program will offer access to a number of services that will better help treat mothers and their babies. The program will offer diagnostic testing, ultrasound, echocardiography and fetal MRI. All diagnostic testing will be performed at Mount Sinai Hospital.

“CHOP is pleased to mark this milestone in the relationship between two health care institutions that are totally dedicated to caring for the health of children and their families,” said Madeline Bell, president and CEO of Children’s Hospital of Philadelphia, in a statement. “The alliance with the Mount Sinai Health System continues to evolve and reflects both a shared vision to better serve families in the New York region and a mutual professional respect and admiration between our organizations.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.